Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is N/A as of Tuesday, October 6, 2026.
ENTERPRISE VALUE (EV)
N/A
Obsidian Therapeutics Inc.
Market Cap
$14.51M
Enterprise Value (EV)
N/A
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $14.51M | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | $11.31M |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.95M | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.10M | $176.01M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.89M | $4.06M |
| IN8bio, Inc. (INAB)vs › | $13.89M | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | $5.85M |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | $14.59M |
| Optimi Health Corp. (OPTH)vs › | $13.56M | $7.98M |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | $21.06M |
Market Cap
$14.51M
Total Debt
N/A
Cash
N/A
Enterprise Value
N/A
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
